Follow us on social

Shutterstock_1681571647-scaled

Lack of international agreement on a COVID-19 vaccine could cause new conflicts

International cooperation and an agreement on equitable access to a new vaccine is in the interest of everyone.

Analysis | Washington Politics

The distribution of a potential vaccine against COVID-19 is likely to become one of the dominating issues that will shape international relations. Countries with the ability to control the production of a vaccine will have the power to influence and put pressure on those that don’t. They can determine the speed of economic recovery of others and use the vaccine as a bargaining tool.

The sprint to develop a vaccine also increases the tensions between the United States and China and has been compared to the race to the moon between the U.S. and the Soviet Union during the Cold War. As the mistrust dominates, no country wants to be second. American security experts have accused China of hacking and obtaining scientific data on the vaccine. The issue of access to a COVID-19 vaccine not only threatens to put a strain on the relations between the great powers, but it can also create new rifts between rich, industrialized countries and developing and emerging nations.

These conflicts are likely to increase if there is no agreement on the distribution of the vaccine and if access depends on the forces of the free market. Governments will try to buy vaccines for their own population, which would cause a global hoarding dynamic. Pharmaceuticals then don’t end up where they are needed most, but in countries that are willing to pay the highest price or are able to exert the greatest pressure on companies. The experience of the swine flu pandemic (H1N1) in 2009 highlighted that a lack of regulation and cooperation disadvantages low- and middle-income countries. In 2009, rich countries had bought virtually all available doses of the H1N1 vaccine.

Given the lack of regulations and the power factor of a COVID-19 vaccine, it is crucial to make an arrangement for fair and equitable distribution now. In the face of global pandemic, an international agreement to ensure global access is in the interest of everyone. Governments benefit from preventing new outbreaks in other countries because the spread of a highly contagious virus can only be contained if there are no new cases elsewhere. It is not sufficient to immunize one’s own population only.

To prevent conflicts and ensure fair, equitable, and global access to a vaccine, the international community should take three steps: prevent excessive pricing, agree on a fair allocation system, and strengthen the infrastructure necessary to distribute a vaccine.

In a situation with high demand and short supply, market forces will drive up the price for a new vaccine, even if pharmaceutical companies don’t take advantage of the situation and inflate the price artificially. At the annual World Health Summit in May, member states of the World Health Organization adopted two resolutions in which they express their willingness to cooperate, and to ensure fair and equitable access to COVID-19 treatment and vaccines at affordable prices.

One possibility to prevent excessive pricing is to use compulsory licensing, through which governments can allow other companies to produce a specific drug or vaccine without the permission of the patent holder. Compulsory licensing is possible under the rules of the World Trade Organization. It should only be used in emergency situations, but it can be a tool under the current circumstances to ensure global access to a COVID-19 vaccine. In Canada, emergency legislation allowed the minister of health to circumvent patent rights if necessary. Four European countries announced to negotiate jointly with pharmaceutical companies to ensure affordable prices.

One of the most sensitive questions will be to agree on the allocation of a new vaccine. The international community needs to build a framework to determine how available vaccine doses should be distributed, how they can be deployed, and who is coordinating the process. Similar to the needs assessments that are common for the provision of humanitarian aid, such a framework for a COVID-19 vaccine needs to take into account the greatest needs, but also changing trends to anticipate the emergence of hotspots and mitigate the impact of new outbreaks.

During the H1N1 pandemic, the WHO Deployment Initiative was established to coordinate vaccine donations and distribute them among developing countries. The WHO acted as a secretariat and implementing body. While countries can learn from the experiences of the H1N1 Deployment Initiative, an operation for COVID-19 will be more complex because of the greater scope and the higher number of actors involved. It is possible that there will be more than one vaccine, with production scattered over different places, and more low- and middle- income countries that request assistance.

A third necessary step will be to strengthen the infrastructure in countries and overcome logistical challenges, such as the lack of cold chains which are usually necessary for the storage and transportation of vaccines.

President Trump in May announced “Operation Warp Speed” — an investment program to develop a vaccine by January. The president also made it clear that he intends to serve the American people, rather than to share a new vaccine. His announcement to cease cooperating with the WHO will make it more difficult — but not impossible — to build a multilateral framework for the distribution of a new COVID-19 vaccine. The time needed to develop a vaccine provides the space to make the arrangements necessary for a quick, fair, effective and efficient distribution of a vaccine ones it is ready.


Image via mi1333/shutterstock.com
Analysis | Washington Politics
Kim Jong Un
Top photo credit: North Korean leader Kim Jong Un visits the construction site of the Ragwon County Offshore Farm, North Korea July 13, 2025. KCNA via REUTERS

Kim Jong Un is nuking up and playing hard to get

Asia-Pacific

President Donald Trump’s second term has so far been a series of “shock and awe” campaigns both at home and abroad. But so far has left North Korea untouched even as it arms for the future.

The president dramatically broke with precedent during his first term, holding two summits as well as a brief meeting at the Demilitarized Zone with the North’s Supreme Leader Kim Jong-un. Unfortunately, engagement crashed and burned in Hanoi. The DPRK then pulled back, essentially severing contact with both the U.S. and South Korea.

keep readingShow less
Why new CENTCOM chief Brad Cooper is as wrong as the old one
Top photo credit: U.S. Navy Vice Admiral Brad Cooper speaks to guests at the IISS Manama Dialogue in Manama, Bahrain, November 17, 2023. REUTERS/Hamad I Mohammed

Why new CENTCOM chief Brad Cooper is as wrong as the old one

Middle East

If accounts of President Donald Trump’s decision to strike Iranian nuclear facilities this past month are to be believed, the president’s initial impulse to stay out of the Israel-Iran conflict failed to survive the prodding of hawkish advisers, chiefly U.S. Central Command (CENTCOM) chief Michael Kurilla.

With Kurilla, an Iran hawk and staunch ally of both the Israeli government and erstwhile national security adviser Mike Waltz, set to leave office this summer, advocates of a more restrained foreign policy may understandably feel like they are out of the woods.

keep readingShow less
Putin Trump
Top photo credit: Vladimir Putin (Office of the President of the Russian Federation) and Donald Trump (US Southern Command photo)

How Trump's 50-day deadline threat against Putin will backfire

Europe

In the first six months of his second term, President Donald Trump has demonstrated his love for three things: deals, tariffs, and ultimatums.

He got to combine these passions during his Oval Office meeting with NATO Secretary General Mark Rutte on Monday. Only moments after the two leaders announced a new plan to get military aid to Ukraine, Trump issued an ominous 50-day deadline for Russian President Vladimir Putin to agree to a ceasefire. “We're going to be doing secondary tariffs if we don't have a deal within 50 days,” Trump told the assembled reporters.

keep readingShow less

LATEST

QIOSK

Newsletter

Subscribe now to our weekly round-up and don't miss a beat with your favorite RS contributors and reporters, as well as staff analysis, opinion, and news promoting a positive, non-partisan vision of U.S. foreign policy.